PRKCA and cryptosporidiosis: Additionally, both pharmacological inhibition and genetic PKCα inhibition have been shown to prevent NHE3 internalization, Na+ malabsorption, and tumor necrosis factor (TNF)-mediated diarrhea, despite continued barrier dysfunction (25), supporting the idea of a role for PRKCA in symptomatic cryptosporidiosis.